Hims & Hers Health, Inc. — Director's Dealing 2023

Sep 19, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Hims & Hers Health, Inc. (HIMS)
CIK: 0001773751
Period of Report: 2023-09-15

Reporting Person: Bard Alex (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-09-15	Class A Common Stock	M	2449	—	Acquired	50146	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-09-15	Restricted Stock Unit	$	M	2226	Disposed		Class A Common Stock (2226)	Direct
2023-09-15	Restricted Stock Unit	$	M	218	Disposed		Class A Common Stock (218)	Direct
2023-09-15	Restricted Stock Unit	$	M	5	Disposed		Class A Common Stock (5)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Class A Common Stock	7349710	Indirect
Class A Common Stock	227305	Indirect

Footnotes

F1: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F2: The Reporting Person is one of several members of Redpoint Ventures VI, L.L.C., the general partner of Redpoint Ventures VI, L.P. ("RV VI"), and Redpoint Associates VI, L.L.C. ("RA VI"). The Reporting Person may be deemed a beneficial owner of the securities held by RV VI and RA VI, but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein.

F3: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of March 15, 2021. The remaining 75% vest in equal quarterly installments over the following three years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date").